Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Outpatient (ex Primary Care)

 

The Philippines: a national survey

The Philippines has tremendous potential. It has one of the world’s fastest growing economies, and yet it doesn’t have many large healthcare service providers and it lacks a medical infrastructure sufficient to cope with all its residents’ needs. Healthcare Nova looks at the current market there, government policy, and how the private sector is changing.

IPOs galore in the UK, Sweden and Finland

A wave of IPOs in the Nordics and the UK look likely in healthcare services. Investec is planning to IPO fast-growth British teleradiology group Medica and East European outpatient player Medicover is supposed to be IPOing in the second quarter in Sweden. Meanwhile the two largest Finnish providers look set to IPO in 2017.

Brazil’s new post-acute business model attracting foreign interest

The post-acute market presents a real opportunity in Brazil, after the ban against foreign investment in hospitals was lifted in 2015. This is according to Martin Benitez, an independent consultant with extensive M&A experience in the Brazilian healthcare market who is involved in just such a transaction. He speaks to Healthcare Nova about his latest project, and the market in general.

FREE BLOG Apps mean primary care can be consolidated

New ehealth apps mean that the primary care sector in emerging markets can be profitably consolidated for the first time. We look at the potential, talk to advisers, investors and operators look and at what will be delivered in the next six months.

MedLife buys Bucharest clinic operator Anima

Romanian healthcare services provider MedLife is buying Bucharest operator Anima, a group of six clinics providing outpatient services to public, private and corporate patients. We speak to Anima’s CEO Cristian Sas.

Aevis’ offer for LifeWatch likely to fail

An offer by the Swiss investor Aevis for the shares of telemedicine group LifeWatch will fail to reach its tender threshold of 67% of controlling equity, say investors.

Find Us